2025 annual financial data
Oncolytics Biotech 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -28,725,000 USD and net income was -28,759,000 USD.
Operating cash flow was -20,112,000 USD.
Get free Oncolytics Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -28,725,000 USD
- Net income
- -28,759,000 USD
- Operating cash flow
- -20,112,000 USD